BioLASCO Taiwan Co (ROCO:6662) Marketable Securities : NT$58.7 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is BioLASCO Taiwan Co Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. BioLASCO Taiwan Co's Marketable Securities for the quarter that ended in Mar. 2024 was NT$58.7 Mil.

BioLASCO Taiwan Co's annual Marketable Securities increased from Dec. 2021 (NT$43.3 Mil) to Dec. 2022 (NT$58.7 Mil) but then stayed the same from Dec. 2022 (NT$58.7 Mil) to Dec. 2023 (NT$58.7 Mil).

BioLASCO Taiwan Co Marketable Securities Historical Data

The historical data trend for BioLASCO Taiwan Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLASCO Taiwan Co Marketable Securities Chart

BioLASCO Taiwan Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

43.30

58.70

BioLASCO Taiwan Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial															58.70	58.70	58.70	58.70	58.70

BioLASCO Taiwan Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

BioLASCO Taiwan Co (ROCO:6662) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

BioLASCO Taiwan Co Marketable Securities Related Terms

Thank you for viewing the detailed overview of BioLASCO Taiwan Co's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

BioLASCO Taiwan Co (ROCO:6662) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioLASCO Taiwan Co Ltd (ROCO:6662) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

3rd Floor, 316 Chong-yang Road, Taipei, TWN, 115

Website

http://www.biolasco.com.tw

BioLASCO Taiwan Co Ltd is a biological experimental development company. The company has produced strains of laboratory rats and mice, including outbreed stocks, inbreed strains, and immunedeficient models. It offers reagent kit and equipment which include Allentown, Biomedical data system, PLAS LABS.

BioLASCO Taiwan Co (ROCO:6662) Headlines

No Headlines